Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 77 | SFEBES2021 | Next issue

Society for Endocrinology BES 2021

Edinburgh, United Kingdom
08 Nov 2021 - 10 Nov 2021

Card image cap
Join us in Edinburgh for the flagship event of the Society for Endocrinology

Oral Communications

Metabolism, Obesity and Diabetes

ea0077oc3.1 | Metabolism, Obesity and Diabetes | SFEBES2021

The serotonin transporter SLC6A4 protects human brown adipose tissue from serotonin-mediated suppression of thermogenesis.

Choong Kwok T’ng , Suchacki Karla , Ramage Lynne , Kelman Alexandra , McNeill Ben , Rodney Stewart , Keegan Matthew , Gray Calum , Manning Jonathan , MacNaught Gillian , Fletcher Alison , Simpson Joanna , Carter Roderick , Morton Nicholas , Homer Natalie , van Beek Edwin , Wakelin Sonia , Stimson Roland

The recent discovery of brown adipose tissue (BAT) in adult humans, which generates heat to maintain body temperature in a cold environment, offers an exciting new strategy to treat obesity and metabolic disease, but our knowledge of human BAT activation is limited. To identify novel pathways regulating human BAT, we undertook RNA sequencing of human brown and white adipocytes. The gene SLC6A4 (encoding the serotonin transporter SERT) was one of the most highly differ...

ea0077oc3.2 | Metabolism, Obesity and Diabetes | SFEBES2021

Comparing the transcriptional landscape between lean and obese mice within the small intestinal segments

Jacobs Margot , West Jason , Rajagopalan Harith , Bewick Gavin

Background: Obesity is a complex metabolic disease characterised by excess adipose tissue, that increases the risk of comorbidities such as type II diabetes. Interventions that rearrange the gut architecture or exclude nutrients from the duodenum promote immediate and long-term anti-diabetic effects, placing the gut front and centre in obesity and diabetes pathology and treatment. Currently, little is known about the pathological changes which occur in the small intestine (SI)...

ea0077oc3.3 | Metabolism, Obesity and Diabetes | SFEBES2021

Sex-specific risk of obesity and cardiometabolic disease in low- and middle-income countries (LMICs): a meta-analysis in 681929 individuals

Melson Eka , Rocha Thais , Zamora Javier , Fernandez-Felix Borja M , Sobhy Soha , Betran Ana Pilar , Arlt Wiebke , Thangaratinam Shakila

Introduction: Obesity is a global health challenge with more than 60% of the world´s population with obesity living in LMICs. Studies have demonstrated that women are more affected by obesity than men. However, the risk of obesity and obesity-related cardiometabolic diseases in women in LMICs have not been documented. The aims of this meta-analysis are: to evaluate the risk of obesity and obesity-related cardiometabolic disease in women compared to men in LMICs and to eva...

ea0077oc3.4 | Metabolism, Obesity and Diabetes | SFEBES2021

Hepatic choline deficiency underpins amelioration of visceral obesity and diabetes in ectonucleotide pyrophosphatase (Enpp)-6–/– mice

Wang Rongling , Schraut Katharina , Carter Roderick , Kentistou Katherine , Wilson James , Michailidou Zoi , Webster Scott , Morton Nicholas

The global prevalence of obesity continues to rise, creating a growing need for new effective medicines. Selective targeting of visceral obesity (fat around the internal organs) would be particularly advantageous because it carries a greater risk for cardiometabolic diseases. The ectonucleotide pyrophosphatase (ENPP) enzyme family participates in several pathological conditions including diabetes (ENPP1, and ENPP2, also known as autotaxin) and vascular dysfunction (ENPP3-4). O...

ea0077oc3.5 | Metabolism, Obesity and Diabetes | SFEBES2021

Microbial tryptophan metabolites modulate L-cell induced GLP-1 secretion to improve glucose homeostasis

Phuah Phyllis , Cheng Sijing , Norton Mariana , Roberts Anna , Otsubo Emile , Gribble Fiona , Reimann Frank , Hanyaloglu Aylin , Owen Bryn , Murphy Kevin

Growing evidence implicates gut microbiota-derived metabolites in metabolic homeostasis. Gut microbial dysbiosis occurs in obesity, while high-fibre and high-protein diets, which improve glucose tolerance and induce weight loss, are associated with the generation of microbial metabolites. Understanding how the gut responds to microbial metabolites may identify mechanisms that induce satiety and improve glucoregulation, revealing novel therapeutic targets. Indole is generated f...

ea0077oc3.6 | Metabolism, Obesity and Diabetes | SFEBES2021

Stimulation of motilin secretion by bile, free fatty acids and acidification in human duodenal organoids

Miedzybrodzka Emily L , Foreman Rachel E , Lu Van B , George Amy L , Smith Christopher A , Larraufie Pierre , Kay Richard G , Goldspink Deborah A , Reimann Frank , Gribble Fiona M

Objective: Motilin is a proximal small intestinal hormone with roles in gastrointestinal motility, gallbladder emptying and hunger initiation. The molecular mechanisms underlying motilin release in response to fats, bile and duodenal acidification are poorly understood, in part due a lack of suitable cellular and rodent models. We therefore generated a novel human intestinal organoid model with fluorescently labelled motilin-expressing M-cells, which we used to establish the k...